News
Explore the latest stories and publications from NCATS and our partners, see upcoming events, or explore the variety of resources we provide to better understand translational science and our work.
News
Read the latest news from NCATS and its collaborators whose research is supported through the Center’s programs, or follow coverage of NCATS' translational research activities through national and local media.
NCATS Report Highlights Decentralized Clinical Trials’ Challenges, Opportunities
June 10, 2024 - NCATS News
- Clinical and Translational Science Awards (CTSA) Program
A new report offers an approach to strengthen and expand decentralized clinical trials, potentially reaching more participants and delivering real-world research findings sooner.
Read ArticleEquitable Breakthroughs in Medicine Development Reaches Next Phase Driving Diversity in Clinical Trials in Georgia, South Carolina, Tennessee, and Texas
February 26, 2024 - Grantee/Partner News
- Clinical and Translational Science Awards (CTSA) Program
NIH Awards $35.5 Million to Use Tiny, Bioengineered Organ Models to Improve Clinical Trials’ Development and Design
September 29, 2020 - NCATS News
- Tissue Chip for Drug Screening
Approximately 85% of late-stage clinical trials of candidate drugs fail because of drug safety problems or ineffectiveness, despite promising preclinical test results.
NIH Expands Clinical Trials to Test Convalescent Plasma Against COVID-19
September 22, 2020 - NCATS News
- COVID-19
- Clinical and Translational Science Awards (CTSA) Program
Two randomized, placebo-controlled clinical trials funded by NIH are expanding enrollment to further evaluate convalescent plasma as a treatment for people hospitalized with COVID-19.
Clinical Trial Readiness Grants Aim to Set the Stage for Rare Disease Clinical Trials
March 17, 2020 - NCATS News
- Genetic and Rare Diseases (GARD) Information Center
To close the gap between development of candidate interventions for rare diseases and clinical testing, NCATS and NICHD created rare-disease Clinical Trial Readiness grants.